Updates are available Correction dated 2025-03-26
Click to view Correction: https://doi.org/10.1038/s41591-025-03667-x
-
Authors
Provenza, Nicole R. https://orcid.org/0000-0002-6952-5417
Reddy, Sandesh
Allam, Anthony K.
Rajesh, Sameer V.
Diab, Nabeel
Reyes, Gabriel https://orcid.org/0009-0007-3209-3319
Caston, Rose M.
Katlowitz, Kalman A.
Gandhi, Ajay D.
Bechtold, Raphael A.
Dang, Huy Q.
Najera, Ricardo A.
Giridharan, Nisha
Kabotyanski, Katherine E.
Momin, Faiza
Hasen, Mohammed
Banks, Garrett P.
Mickey, Brian J.
Kious, Brent M.
Shofty, Ben https://orcid.org/0000-0002-2949-4740
Hayden, Benjamin Y.
Herron, Jeffrey A. https://orcid.org/0000-0002-9813-0094
Storch, Eric A.
Patel, Ankit B.
Goodman, Wayne K.
Sheth, Sameer A. https://orcid.org/0000-0001-8770-8965
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (UH3NS100549, UH3NS100549, UH3NS100549, UH3NS100549, UH3NS100549)
Robert and Janice McNair Foundation
- License Information
-
More Information
Article History
Received: 21 July 2023
Accepted: 11 June 2024
First Online: 12 July 2024
Change Date: 26 March 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41591-025-03667-x
Competing interests
: S.A.S. has been a consultant for Boston Scientific, Zimmer Biomet, Koh Young, Sensoria Therapeutics, Varian Medical Systems, Abbott and Neuropace and is co-founder of Motif Neurotech. W.K.G. receives royalties from Nview, LLC and OCDscales, LLC. E.A.S. reports receiving research funding to his institution from the Ream Foundation, the International OCD Foundation and the National Institutes of Health. He was formerly a consultant for Brainsway and Biohaven Pharmaceuticals in the past 12 months. He owns stock less than $5,000 in NView/Proem for distribution related to the Y-BOCS scales. He receives book royalties from Elsevier, Wiley, Oxford, the American Psychological Association, Guildford, Springer, Routledge and Jessica Kingsley. A.B.P. has been an advisor to Endoluxe, CSDISCO and SCAN Health Plan and is co-founder and CEO of Audit AI. B.J.M. has received research support from LivaNova and Health Rhythms in the past 2 years. The other authors declare no competing interests.
